{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:07:19Z","timestamp":1778760439020,"version":"3.51.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Anlotinib is a novel multi-target tyrosine kinase inhibitor (TKI) that targets tumor angiogenesis and proliferation signals, demonstrating significant antiangiogenic effects. It is used as a third-line treatment for refractory advanced non-small cell lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>An elderly male patient with lung squamous cell carcinoma, who was intolerant to chemotherapy, received anlotinib for antitumor treatment and experienced choking when eating and drinking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Pulmonary computed tomography revealed an irregular cavity adjacent to the mediastinum in the right lung, measuring ~75 mm\u2005\u00d7\u200549\u2009mm. Endoscopic examination combined with gastroscopy and tracheoscopy under general anesthesia showed erosion of the carina, absence of the right side, and an ~3-cm-long, oval-shaped esophagotracheal fistula located 26 to 29\u2009cm from the incisors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>A partially covered esophageal stent was placed endoscopically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>During the 6-month follow-up period, the patient\u2019s esophagotracheal fistula narrowed, and he no longer experienced choking while eating or drinking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The incidence of adverse reactions to anlotinib is relatively low, and esophago-tracheobronchial fistula caused by it is even rarer. When using anlotinib to treat non-small cell lung cancer, clinicians need to monitor changes in patients\u2019 symptoms closely. If symptoms of choking when eating and drinking occur, pulmonary computed tomography should be promptly repeated to detect signs of esophago-tracheobronchial fistula early and intervene promptly.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046215","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:01:33Z","timestamp":1764169293000},"page":"e46215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Esophago-tracheobronchial fistula induced by anlotinib: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Yiheng","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabin","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thorsurg.2018.04.007","article-title":"Management of malignant tracheoesophageal fistula.","volume":"28","author":"Shamji","year":"2018","journal-title":"Thorac Surg Clin"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0039-3400284","article-title":"ERNICA consensus conference on the management of patients with esophageal atresia and tracheoesophageal fistula: follow-up and framework.","volume":"30","author":"Dingemann","year":"2020","journal-title":"Eur J Pediatr Surg"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MAJ.0000000000000565","article-title":"Airway covered metallic stent based on different fistula location and size in malignant tracheoesophageal fistula.","volume":"350","author":"Wang","year":"2015","journal-title":"Am J Med Sci"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jfma.2024.05.014","article-title":"Risk factors of stent migration in esophageal cancer patients who underwent fully-covered self-expanding metal stents for malignant dysphagia or tracheoesophageal fistula.","volume":"124","author":"Chou","year":"2024","journal-title":"J Formosan Med Assoc"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.2147\/DDDT.S426898","article-title":"Research progress on mechanism and management of adverse drug reactions of anlotinib.","volume":"17","author":"Li","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bjh.15000","article-title":"Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases.","volume":"180","author":"Yang","year":"2018","journal-title":"Br J Haematol"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms19051269","article-title":"VEGF (Vascular Endothelial Growth Factor) and fibrotic lung disease.","volume":"19","author":"Barratt","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets.","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"R9-20260514","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gene.2018.02.026","article-title":"\u201cAnlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFR\u03b2 and FGFR1.\u201d","volume":"654","author":"Lin","year":"2018","journal-title":"Gene"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"200094","DOI":"10.1183\/16000617.0094-2020","article-title":"Management of tracheo-oesophageal fistula in adults.","volume":"29","author":"Kim","year":"2020","journal-title":"Eur Respir Rev"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.3390\/jcm13237382","article-title":"Successful treatment of an esophago-tracheobronchial fistula using double stenting to correct initial stent migration: a case report and literature review.","volume":"13","author":"Nishio","year":"2024","journal-title":"J Clin Med"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jamaoncol.2018.3039","article-title":"Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the ALTER 0303 phase 3 randomized clinical trial [published correction appears in.","volume":"4","author":"Han","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:08:05Z","timestamp":1778756885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":12,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046215","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-06-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}